Where the best science comes to meet
Infectious diseases have always impacted human history, but in the past 50 years we have managed to control or eliminate some infectious diseases through improved hygiene, vaccination, antimicrobials, advances in medicine and public health policies. However, the current pandemic is a reminder thatwe need to continue to pursue our efforts to control these pathogens, especially with intercontinental travel and increased mobility of people and animals.
To manage infectious diseases, we use tools such as vaccines, antibiotics, antivirals, diagnostic tools and biomarkers. But today there are many infectious diseases for which we do not have satisfactory preventive tools or treatment options, such as SARS-CoV-2, Zika virus, Ebola virus, multidrug resistant bacteria, HIV, Malaria. To develop these future tools, collaboration is essential, either for sourcing assets in the vaccine, antiviral or antibiotic space, or for finding research tools to help in screening, in-vivo modelling, clinical trials and diagnostics and biomarkers.
It is in this context that we are organising the Infectious Diseases Virtual Partnering event, focusing on diseases caused by organisms such as bacteria, viruses, fungi, or parasites. With current travel restrictions, this virtual event will help you to find the right business partner to pursue your objectives.
Date: 2 – 4 December 2020
MVA member discount: MVA members gets 15% discount by using the code KQFSLSXV
This event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide.